v3.22.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance at the beginning of period (in shares) at Dec. 31, 2020   1,792,140,000      
Balance at beginning of period at Dec. 31, 2020 $ 1,522,550 $ 1,792 $ 6,488,857 $ (2,745) $ (4,965,354)
Issuance of common stock from the exercise of stock options (in shares)   114,471,000      
Issuance of common stock from the exercise of stock options 376,688 $ 114 376,574    
Issuance of common stock upon vesting of RSUs (in shares)   23,832,000      
Issuance of common stock upon vesting of RSUs 0 $ 24 (24)    
Issuance of common stock upon vesting of growth units (in shares)   1,471,000      
Issuance of common stock upon vesting of growth units 0 $ 1 (1)    
Issuance of common stock upon net exercise of common stock warrants (in shares)   4,664,000      
Issuance of common stock upon net exercise of common stock warrants and other 1,712 $ 6 1,706    
Stock-based compensation 427,257   427,257    
Other comprehensive loss 2,810     2,810  
Net loss (262,054)       (262,054)
Balance at end of period (in shares) at Jun. 30, 2021   1,936,578,000      
Balance at end of period at Jun. 30, 2021 2,068,963 $ 1,937 7,294,369 65 (5,227,408)
Balance at the beginning of period (in shares) at Mar. 31, 2021   1,860,607,000      
Balance at beginning of period at Mar. 31, 2021 1,805,943 $ 1,860 6,892,046 865 (5,088,828)
Issuance of common stock from the exercise of stock options (in shares)   59,171,000      
Issuance of common stock from the exercise of stock options 167,828 $ 59 167,769    
Issuance of common stock upon vesting of RSUs (in shares)   12,872,000      
Issuance of common stock upon vesting of RSUs 0 $ 13 (13)    
Issuance of common stock upon net exercise of common stock warrants (in shares)   3,928,000      
Issuance of common stock upon net exercise of common stock warrants and other 1,712 $ 5 1,707    
Stock-based compensation 232,860   232,860    
Other comprehensive loss (800)     (800)  
Net loss (138,580)       (138,580)
Balance at end of period (in shares) at Jun. 30, 2021   1,936,578,000      
Balance at end of period at Jun. 30, 2021 $ 2,068,963 $ 1,937 7,294,369 65 (5,227,408)
Balance at the beginning of period (in shares) at Dec. 31, 2021 2,027,474,000 2,027,474,000      
Balance at beginning of period at Dec. 31, 2021 $ 2,291,030 $ 2,027 7,777,085 (2,349) (5,485,733)
Issuance of common stock from the exercise of stock options (in shares) 11,434,000 11,434,000      
Issuance of common stock from the exercise of stock options $ 47,541 $ 12 47,529    
Issuance of common stock upon vesting of RSUs (in shares)   23,833,000      
Issuance of common stock upon vesting of RSUs 0 $ 24 (24)    
Stock-based compensation 295,286   295,286    
Other comprehensive loss (4,325)     (4,325)  
Net loss $ (280,708)       (280,708)
Balance at end of period (in shares) at Jun. 30, 2022 2,062,741,000 2,062,741,000      
Balance at end of period at Jun. 30, 2022 $ 2,348,824 $ 2,063 8,119,876 (6,674) (5,766,441)
Balance at the beginning of period (in shares) at Mar. 31, 2022   2,045,876,000      
Balance at beginning of period at Mar. 31, 2022 2,364,746 $ 2,046 7,953,856 (4,044) (5,587,112)
Issuance of common stock from the exercise of stock options (in shares)   4,780,000      
Issuance of common stock from the exercise of stock options 20,316 $ 5 20,311    
Issuance of common stock upon vesting of RSUs (in shares)   12,085,000      
Issuance of common stock upon vesting of RSUs 0 $ 12 (12)    
Stock-based compensation 145,721   145,721    
Other comprehensive loss (2,630)     (2,630)  
Net loss $ (179,329)       (179,329)
Balance at end of period (in shares) at Jun. 30, 2022 2,062,741,000 2,062,741,000      
Balance at end of period at Jun. 30, 2022 $ 2,348,824 $ 2,063 $ 8,119,876 $ (6,674) $ (5,766,441)